Britain's Terry Smith made public for the first time on Thursday why his fund dumped its Diageo stake last year, citing ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

The use of GLP-1 drugs sparked the term "Ozempic shaming" to describe the negative perceptions faced by those who choose ...

The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss management program.

Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...

Polls provide a useful window into understanding how Americans view their own weight and the recent availability of drugs ...

New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.

As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the ...

Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...

Eli Lilly has asked to join in opposing a lawsuit brought by compounding pharmacies against the U.S. Food and Drug ...